Investor Hits BioMimetic With Fraud Action
A BioMimetic Therapeutics Inc. investor filed a securities class action Wednesday in Tennessee accusing the medical device maker of lying about the progress of approval for a new bone injury treatment,...To view the full article, register now.
Already a subscriber? Click here to view full article